Maze Therapeutics, Inc. — All Filings
140 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B3
424B4
8-A12B
8-K
CERT
CORRESP
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001193125-26-122778 | Mar 25, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-122774 | Mar 25, 2026 | Mar 24, 2026 |
| 4 | — | 0002050172-26-000017 | Mar 20, 2026 | — |
| 4 | — | 0002050172-26-000015 | Mar 12, 2026 | Mar 10, 2026 |
| 144 | — | 0001950047-26-002427 | Mar 10, 2026 | — |
| 4 | — | 0001787359-26-000002 | Mar 3, 2026 | Mar 2, 2026 |
| 4 | — | 0001782758-26-000002 | Mar 3, 2026 | Mar 2, 2026 |
| 4 | — | 0002050167-26-000005 | Mar 3, 2026 | Feb 27, 2026 |
| 4 | — | 0002050172-26-000013 | Mar 3, 2026 | Mar 2, 2026 |
| 4 | — | 0002050422-26-000010 | Mar 3, 2026 | Mar 2, 2026 |
| 4 | — | 0001676170-26-000002 | Mar 3, 2026 | Mar 2, 2026 |
| SCHEDULE 13G/A | — | 0001231919-26-000147 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-26-051800 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0001168404-26-000010 | Feb 6, 2026 | — |
| S-8 | S-8 | 0001193125-26-037839 | Feb 4, 2026 | — |
| S-3ASR | S-3ASR | 0001193125-26-037831 | Feb 4, 2026 | — |
| 8-K | 8-K | 0001193125-26-037747 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | — | 0002050172-26-000009 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | — | 0002050422-26-000008 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | — | 0002050167-26-000003 | Feb 2, 2026 | Jan 29, 2026 |
| 4 | — | 0002050422-26-000005 | Jan 26, 2026 | Jan 22, 2026 |
| 144 | — | 0001950047-26-000526 | Jan 16, 2026 | — |
| 4 | — | 0002050172-26-000006 | Jan 9, 2026 | Jan 7, 2026 |
| 4 | — | 0001555132-26-000006 | Jan 8, 2026 | Jan 6, 2026 |
| 144 | — | 0001950047-26-000221 | Jan 7, 2026 | — |
| 144 | — | 0001950047-26-000213 | Jan 6, 2026 | — |
| 4 | — | 0002050172-26-000003 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | — | 0002050422-26-000003 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | — | 0002050167-25-000007 | Dec 31, 2025 | Dec 29, 2025 |
| 4 | — | 0002050172-25-000007 | Dec 31, 2025 | Dec 29, 2025 |
| 4 | — | 0002050422-25-000007 | Dec 31, 2025 | Dec 29, 2025 |
| 144 | — | 0001950047-25-010743 | Dec 29, 2025 | — |
| 144 | — | 0001950047-25-010731 | Dec 29, 2025 | — |
| 144 | — | 0001950047-25-009757 | Dec 4, 2025 | — |
| 4 | — | 0001192591-25-000010 | Nov 21, 2025 | Nov 19, 2025 |
| 144 | — | 0001950047-25-009187 | Nov 21, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-112467 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-004912 | Nov 13, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-269689 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-269624 | Nov 6, 2025 | — |
| 424B3 | 424B3 | 0001193125-25-269557 | Nov 6, 2025 | — |
| 4 | 4 | 0001193125-25-266981 | Nov 5, 2025 | Nov 4, 2025 |
| 4 | — | 0001192591-25-000008 | Oct 27, 2025 | Oct 23, 2025 |
| S-1 | S-1 | 0001193125-25-242526 | Oct 17, 2025 | — |
| 4 | — | 0001596492-25-000006 | Oct 7, 2025 | Oct 6, 2025 |
| 3 | — | 0001596492-25-000005 | Oct 7, 2025 | Oct 6, 2025 |
| 8-K | 8-K | 0001193125-25-230926 | Oct 6, 2025 | — |
| 4 | — | 0001782758-25-000005 | Sep 24, 2025 | Sep 22, 2025 |
| 4 | — | 0002050167-25-000004 | Sep 24, 2025 | Sep 22, 2025 |
| 4 | — | 0001676170-25-000008 | Sep 24, 2025 | Sep 22, 2025 |